drugset / Trial / NCT06700148
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year Olds
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This is a randomized, blinded, peer-controlled study. There will be 2 treatment groups, screened subjects were given study numbers in the order of enrollment and randomly assigned to the test and control groups in a 1:1 ratio. Subjects were required to complete a 1-dose immunization program with 0.5 ml of vaccine in both the test and control groups, afterwards some subjects entered the immune persistence group.
Timeline
- Start
- 2024-12-14
- Primary completion
- 2025-08-30
- Completion
- 2025-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MCV4 | Vaccine | 0.5 ml | — |
| Comparator | MPSV4 | Vaccine | 0.5 ml | — |